Lakshmi Amaravadi
Seminars
Wednesday 10th March 2027
Expanding ADC Use Across Tumour Types & Patient Populations for Difficult to Treat Solid Tumours Including Pancreatic, Glioblastoma, and Sarcomas
2:15 pm
- Developing stage-appropriate bioanalytical strategies for conventional and dual-payload ADCs
- Using clinical case studies to inform ADC immunogenicity assessment across indications and development stages
- Applying science- and risk-based approaches to dual-payload ADCs and combinations
